BGI Tech Solutions

BGI Tech, START collaborate on 1000 Cancer Genome Project

Monday, October 7, 2013

BGI Tech Solutions, a subsidiary of BGI, a genomics research organization, and South Texas Accelerated Research Therapeutics (START), are collaborating on the San Antonio 1000 Cancer Genome Project (SA1kCGP), a cancer genome study designed to link genetic alterations that underlie different cancers to detailed clinical outcomes. Such findings could enable scientists to pursue the development of targeted, personalized cancer treatments. All data generated from SA1kCGP will be made available publicly and freely to researchers and others worldwide.

[Read More]

Roche, BGI develop advanced MHC technology

Monday, November 28, 2011

Roche NimbleGen and BGI have developed a major histocompatibility complex (MHC) region capture technology based on NimbleGen SeqCap EZ Choice Library, a process for the enrichment of the MHC region. This newly developed approach allows easy capture and enrichment of these highly repetitive regions and enables the generation of deep sequencing coverage of the human MHC region. This new sample preparation approach overcomes the limitations of traditional methods of PCR and genomic enrichment used for disease and drug research. 

[Read More]

Merck, BGI collaborate

Tuesday, September 13, 2011

Merck and BGI have established a collaboration to focus on the discovery and development of biomarkers and genomic technologies. Under the agreement scientists from Merck and BGI will work closely together to identify and characterize biomarkers with an emphasis on drug discovery, drug development and diagnostics applications across a wide range of therapeutic areas.

[Read More]